Scientists inch closer and closer to an HIV vaccine, and Harvard University has just taken an important step. A new 'mosaic' vaccine was able to generate positive results in both humans and rhesus monkeys.
After years of study, the first HIV vaccine efficacy clinical trials will begin in South Africa, with thousands of local adult volunteers.
Scientists have discovered an antibody that could neutralize 98 percent of HIV strains. The discovery could bring scientists closer to finding a way to prevent HIV transmission.